ReviewEuropean journal of medicinal chemistry2021

Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy.

Mengjiao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.